Capital Research Global Investors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.2M | Buy |
1,776,812
+14,654
| +0.8% | +$563K | 0.01% | 320 |
|
|
2025
Q1 | $68.3M | Buy |
1,762,158
+2,950
| +0.2% | +$114K | 0.01% | 333 |
|
|
2024
Q4 | $59.5M | Buy |
1,759,208
+4,715
| +0.3% | +$159K | 0.01% | 347 |
|
|
2024
Q3 | $71.7M | Hold |
1,754,493
| – | – | 0.01% | 312 |
|
|
2024
Q2 | $67.5M | Buy |
1,754,493
+1,458
| +0.1% | +$56.1K | 0.01% | 313 |
|
|
2024
Q1 | $75.2M | Hold |
1,753,035
| – | – | 0.02% | 308 |
|
|
2023
Q4 | $65M | Hold |
1,753,035
| – | – | 0.02% | 304 |
|
|
2023
Q3 | $63.5M | Buy |
1,753,035
+685
| +0% | +$24.8K | 0.02% | 311 |
|
|
2023
Q2 | $62.5M | Buy |
1,752,350
+1,032
| +0.1% | +$36.8K | 0.02% | 315 |
|
|
2023
Q1 | $62.3M | Buy |
1,751,318
+1,140
| +0.1% | +$40.6K | 0.02% | 311 |
|
|
2022
Q4 | $61.5M | Sell |
1,750,178
-88
| -0% | -$3.09K | 0.02% | 313 |
|
|
2022
Q3 | $51.5M | Sell |
1,750,266
-2,703,892
| -61% | -$79.6M | 0.02% | 316 |
|
|
2022
Q2 | $242M | Sell |
4,454,158
-1,013
| -0% | -$55.1K | 0.08% | 193 |
|
|
2022
Q1 | $243M | Buy |
4,455,171
+161
| +0% | +$8.77K | 0.06% | 224 |
|
|
2021
Q4 | $246M | Sell |
4,455,010
-603
| -0% | -$33.2K | 0.05% | 227 |
|
|
2021
Q3 | $213M | Buy |
4,455,613
+574
| +0% | +$27.4K | 0.05% | 242 |
|
|
2021
Q2 | $222M | Sell |
4,455,039
-117,688
| -3% | -$5.86M | 0.05% | 234 |
|
|
2021
Q1 | $204M | Buy |
4,572,727
+821
| +0% | +$36.6K | 0.05% | 242 |
|
|
2020
Q4 | $210M | Buy |
4,571,906
+576,903
| +14% | +$26.5M | 0.05% | 239 |
|
|
2020
Q3 | $188M | Buy |
3,995,003
+291,087
| +8% | +$13.7M | 0.06% | 221 |
|
|
2020
Q2 | $189M | Buy |
3,703,916
+3,703,757
| +2,329,407% | +$189M | 0.06% | 214 |
|
|
2020
Q1 | $7K | Buy |
+159
| New | +$7K | ﹤0.01% | 394 |
|